232 related articles for article (PubMed ID: 3663266)
21. [The action of tiadenol on compensatory hypertrophy of the liver in the rat].
Rozé C; Vaille C; Souchard M; De la Tour J; Debray C
Arch Int Pharmacodyn Ther; 1976 Jul; 222(1):166-76. PubMed ID: 984967
[TBL] [Abstract][Full Text] [Related]
22. Microsomal lauric acid hydroxylase activities after treatment of rats with three classical cytochrome P450 inducers and peroxisome proliferating compounds.
Dirven HA; van den Broek PH; Peters JG; Noordhoek J; Jongeneelen FJ
Biochem Pharmacol; 1992 Jun; 43(12):2621-9. PubMed ID: 1632818
[TBL] [Abstract][Full Text] [Related]
23. Role of 3,4-dichlorophenyl methyl sulfone, a metabolite of o-dichlorobenzene, in the changes in hepatic microsomal drug-metabolizing enzymes caused by o-dichlorobenzene administration in rats.
Kato Y; Kimura R
Toxicol Appl Pharmacol; 1997 Aug; 145(2):277-84. PubMed ID: 9266800
[TBL] [Abstract][Full Text] [Related]
24. The hypolipidemic peroxisome-proliferating drug, bis(carboxymethylthio)-1.10 decane, a dicarboxylic metabolite of tiadenol, is activated to an acylcoenzyme A thioester.
Aarsland A; Berge RK; Bremer J; Aarsaether N
Biochim Biophys Acta; 1990 Feb; 1033(2):176-83. PubMed ID: 2306462
[TBL] [Abstract][Full Text] [Related]
25. Hepatic microbody proliferation and catalase synthesis induced by methyl clofenapate, a hypolipidemic analog of CPIB.
Reddy JK
Am J Pathol; 1974 Apr; 75(1):103-18. PubMed ID: 4825610
[TBL] [Abstract][Full Text] [Related]
26. Regulation of CYP4A expression in rat by dehydroepiandrosterone and thyroid hormone.
Webb SJ; Xiao GH; Geoghegan TE; Prough RA
Mol Pharmacol; 1996 Feb; 49(2):276-87. PubMed ID: 8632760
[TBL] [Abstract][Full Text] [Related]
27. Drug control of steroid metabolism by the hepatic endoplasmic reticulum.
Feuer G
Drug Metab Rev; 1983; 14(6):1119-44. PubMed ID: 6373207
[TBL] [Abstract][Full Text] [Related]
28. Antihepatotoxic properties of uridine-diphosphoglucose in liver fluke infection. Experimental fascioliasis in the rat.
Maffei Facino R; Carini M; Genchi C; Tofanetti O; Casciarri I; Bedoschi D
Arzneimittelforschung; 1990 Apr; 40(4):490-8. PubMed ID: 2113387
[TBL] [Abstract][Full Text] [Related]
29. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
Marsman D
Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
[TBL] [Abstract][Full Text] [Related]
30. [Effect of the cholesterol and protein diet on cytochrome P-450 dependent monooxygenase activity].
Plewka A; Kamiński M
Med Pr; 1995; 46(1):17-23. PubMed ID: 9732843
[TBL] [Abstract][Full Text] [Related]
31. Influence of dietary carbohydrates (alpha-saccharides) on hepatic drug metabolism in male rats.
Sonawane BR; Coates PM; Yaffe SJ; Koldovsky O
Drug Nutr Interact; 1983; 2(1):7-16. PubMed ID: 6678749
[TBL] [Abstract][Full Text] [Related]
32. Dietary influences on the hepatic mixed-function oxidase system in the rat after portacaval anastomosis.
Proia AD; Edwards KD; McNamara DJ; Anderson KE
Gastroenterology; 1984 Apr; 86(4):618-26. PubMed ID: 6698363
[TBL] [Abstract][Full Text] [Related]
33. The effect of cyclosporine A on renal and hepatic microsomal mixed function oxidase systems in rats.
Machková Z; Mostecká H; Seifert J; Masek K
Methods Find Exp Clin Pharmacol; 1990 May; 12(4):239-44. PubMed ID: 2374470
[TBL] [Abstract][Full Text] [Related]
34. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
35. Effect of repeated administration of monomethyl-aminoantipyrine on the activities of gamma-glutamyltranspeptidase and microsomal drug metabolizing enzymes in rat liver.
Hoshi K; Senda N; Igarashi T; Satoh T; Ueno K; Kitagawa H
Res Commun Chem Pathol Pharmacol; 1985 Jun; 48(3):431-43. PubMed ID: 2862671
[TBL] [Abstract][Full Text] [Related]
36. Dietary cholesterol-induced changes of xenobiotic metabolism in liver. II. Effects of phenobarbitone and carbon tetrachloride on activities of drug-metabolizing enzymes.
Hietanen E; Ahotupa M; Heikelä A; Laitinen M
Drug Nutr Interact; 1982; 1(4):313-27. PubMed ID: 6821390
[TBL] [Abstract][Full Text] [Related]
37. Concurrent subacute exposure to arsenic through drinking water and malathion via diet in male rats: effects on hepatic drug-metabolizing enzymes.
Naraharisetti SB; Aggarwal M; Sarkar SN; Malik JK
Arch Toxicol; 2008 Aug; 82(8):543-51. PubMed ID: 18528686
[TBL] [Abstract][Full Text] [Related]
38. Enzymatic changes in rat liver associated with low and high doses of a peroxisome proliferator.
Berge RK; Hosøy LH; Aarsland A; Bakke OM; Farstad M
Toxicol Appl Pharmacol; 1984 Mar; 73(1):35-41. PubMed ID: 6143426
[TBL] [Abstract][Full Text] [Related]
39. Effect of hypolipidemic compounds on lauric acid hydroxylation and phase II enzymes.
Thomas H; Schladt L; Knehr M; Post K; Oesch F; Boiteux-Antoine AF; Fournel-Gigleux S; Magdalou J; Siest G
Biochem Pharmacol; 1989 Jun; 38(12):1963-9. PubMed ID: 2500933
[TBL] [Abstract][Full Text] [Related]
40. [Induction by kopsinine of hepatic mixed-function oxidase in mice].
Huang WY; Liu GT
Zhongguo Yao Li Xue Bao; 1990 May; 11(3):264-8. PubMed ID: 2088003
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
